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ABSTRACT 

Poly (C) binding protein 1 (PCBPl) is a single stranded DNA binding protein that 
belongs to the K Homology (KH) domain superfamily of proteins. Studies have shown that 
PCBPl is involved in the regulation of f.1-opioid receptor and translational regulation of several 
other proteins. In order to understand the versatile functional roles ofPCBPl, PCBPI interacting 
proteins were identified by screening a human brain cDNA library using a bacterial two hybrid 
system. One of the positive clones was sequenced and identified as RACKl protein. The goal of 
this study is to characterize the physical interaction between PCBPI and RACKl, and study the 
functional effect. The in vivo interaction between these two proteins was validated by a bacterial 
two hybrid system, and the physical interaction in the mammalian system was confirmed using a 
co-immunoprecipitation assay. RACKl has seven tryptophan and aspartic acid (WO) domains. 
Several WO truncated forms of RACKl were constructed and the binding of PCBPl with 
RACKl constructs was mapped at the W07 domain. RACK 1 's functional role was further 
examined by a luciferase reporter assay, where overexpression of RACKI decreased the f.1­
opioid receptor (MOR) promoter activity. In addition, a significant increase ofMOR mRNA and 
protein levels was found in cells transfected with RACKl siRNA. In summary, this study reports 
a unique role of RACKl physically interacting with PCBPI and regUlating the human MOR 
gene expression. 
vii 
t 
I 
t 
l 
Introduction 
Opioids like morphine have a long history as analgesic agents for pain management. The 
analgesic effect of opioids is mainly mediated through binding with opioid receptors located in 
the brain and the spinal cord (Kanjhan, 1995). In addition to inducing an analgesic effect, opioids 
are also known to exhibit undesirable side effects which are the limiting factors of their 
therapeutic use in chronic pain management (Dietis et aI., 2011). Opioid receptors belong to the 
G protein-coupled receptor (GPCR) family, characterized by the presence of seven 
transmembrane domains, where receptor agonists activate signal transduction pathways which 
ultimately mediate downstream cellular responses (Simonds, 1988). GPCRs interact with ligands 
and modulate signal transduction processes using second messengers such as cAMP, inositol 
phosphate and calcium which ultimately regulate the cellular responses (Ferguson et aI., 1996). 
Many GPCRs are known to be involved in diseases and are targeted therapeutically by modern 
drugs (Yeagle and Albert, 2007). 
The opioid receptors are classified into three major types, J.l, Band K according to 
pharmacological studies and molecular cloning (Kieffer et aI., 1992, Chen et aI., 1993). Upon 
ligand binding all three receptors get activated and affect signaling pathways which mediate 
functions and pharmacological effects of opioids (Kieffer and Gaveriaux-Ruff, 2002). The three 
opioid receptors are encoded by three different genes, yet they have high degree of sequence 
homology and each type of receptor has several splice variants as a result of differential mRNA 
processing (Knapp et aI., 1995, Wei and Loh, 2011). 
Mu opioid receptor (MOR) gene and structural characteristics 
The morphine effect is mediated by the J.l opioid receptor in the central nervous system. 
Binding of morphine to the J.l opioid receptor is a critical step in the development of physical 
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dependence (Gharagozlou et aI., 2003). The J.1 opioid receptor plays a critical role in morphine-
induced analgesia, tolerance and dependence as seen from the pharmacological study and 
analysis of the MOR knockout mice (Narita et aI., 1999). The J! opioid receptor was cloned by 
several groups (Kieffer, 1992, Evans, 1992, Chen et aI., 1993). The cDNA clone termed MOR-l, 
is composed of 4 exons and its seven transmembrane domains are encoded by the first 3 exons 
and the 4th exon encodes the last 12 amino acids of the intracellular C-terminus of the receptor. 
Two of the splice variants MOR-IA, and MOR-IB of the cloned J.1 opioid receptor have been 
studied and these variants show the same selectivity for the ligand (Bare et aI., 1994, Pasternak, 
2005). The MOR-l gene has two different promoters, distal and proximal, located within 1 
kilobase upstream of the translational start site (ATG) (Ko et at, 1997). Transcription is initiated 
at the distal promoter from a single transcription initiation site, located 794 bp upstream of the 
translation start site. The proximal promoter initiates the J.1 opioid receptor transcription from the 
four major transcription initiation sites located in a 291 to 268 bp region upstream of the 
translation start site (Min et aI., 1994). 
There are several elements that are responsible for the regulation of MOR expression, by 
targeting the promoter activities; I) the proximal promoter is regulated by the cis acting elements, 
II) trans-acting factors including a neuron-restrictive silencer element, III) an activator protein-a­
like element, IV) specificity pr:o~in (Sp) binding sites (Ko et aI., 1997, Ko et aI., 2003, Kim et 
aI., 2005). Using yeast one-hybrid screening system, poly (C) binding protein I (PCBPl) was 
identified as a single stranded DNA (ssDNA) binding protein which binds to the single stranded 
(ss) polypyrimidine (PPy) element of the MOR proximal promoter and regulates the MOR gene 
expression (Ko and Loh, 2005). 
9 

The K Homology (KH) Domain superfamily and PCBPs 
PCBPI belongs to the KH domain superfamily (Krecic and Swanson, 1999). In archaea, 
bacteria and eukarya, KH domain is found in several proteins that share similar structural 
features (Makeyev and Liebhaber, 2002). The KH motif is comprised of approximately 70 amino 
acids (Valverde et al., 2008). Initial studies identifying the characteristics of the KH domain have 
shown that it comprises of 45 amino acid motifs and subsequent studies have defined a more 
extensive 68-72 residue KH maxi domain (Siomi et al., 1994, Musco et al., 1996). Nuclear 
magnetic resonance (NMR) spectroscopic and X-ray crystallographic analysis of a number of 
KH domains have revealed that the initially described 45 residue core is configured as a fJaafJ 
unit forming a secondary structure (Musco et al., 1996, Baber et al., 1999, Wimberly et aI., 
2000). A variable linker region connecting the multiple domains in hnRNP proteins is one of the 
most prevalent features of the protein. The presence of the RRM (RNA Recognition Motif) 
characterized by a pl-al-p2-p3-a2-p4 structure along with two highly degenerate 
ribonucleoprotein (RNP) consensus sequences, RNP-l and RNP-2 are characteristic to hnRNPs 
(Hoffinan et aL, 1991). 
PCBPI is a protein approximately 38 kDa in size and comprises of two subsets in 
mammalian cells; hnRNP KlJ and the aCP proteins (Matunis et al., 1992, Makeyev and 
Liebhaber, 2002, Rivera et aL, 2004, Malik et al., 2006). The aCPs are encoded at four loci, with 
additional isoforms generated via alternative splicing. aCP-l and aCP-2 are well studied and are 
alternatively referred to as PCBPI and PCBP2 or hnRNP-El and hnRNP-E2 (Makeyev and 
Liebhaber, 2002). PCBPs are defined by their KH structure and their ability to recognize poly 
10 

(C) rich regions in DNA and RNA (Ostareck-Iederer et al.t 1998t Ko et al.t 2003, Malik et aI., 
2006). There are five PCBP loci: HNRNPK and PCBPl, 2, 3, and 4 (Makeyev and Liebhaber, 
2002). PCBPI contains three KH domains, two KH domains grouped at N terminal while the 
third domain is located at the C terminal. The three domains are separated by an intervening 
region of variable length (Makeyev and Liebhaber, 2002, Choi et al., 2005). The variable region 
contains a nuclear localization signal (NLS) that allows shuttling of PCBPI between the nucleus 
and the cytoplasm (Berry et aI., 2006). The ability of PCBPs to recognize and bind poly (C) rich 
DNA and RNA sequences via their KH domains is critical for their function in mammalian cells 
(Malik et aI., 2006). The triple KH domain structure common to all PCBPs does not dominate 
their capacity to bind to poly (C) regions. There are several proteins like the Nova-l and Nova-2 
that also share the triple KH domain structure and exhibit different specificity to bind to the poly 
(C) regions (Yang et al., 1998). Hencet PCBPs are defined by the presence of triple KH domains 
and their capacity to bind to poly (C) regions. 
peBP 
Adapted from Malik et aI., 2006 
Figure: 1 Schematic representation of PCBPI and the three KH domains 
PCBPI contains three KH domains, two of the KH domains located at the N terminal and one 
KH domain is located at the C terminal. All the three domains are separated with an intervening 
region ofvariable length; within this variable region is the nuclear localization signal. 
11 
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Role ofPCBPs in biological processes 
The structural diversity among PCBPs plays an important role in the different functions 
these proteins mediate. Members ofthe KH domain superfamily have been shown to be involved 
in various biological processes from mRNA stabilization to transcriptional and translational 
regulation (Kiledjian et al., 1997, Choi et aL, 2009). Studies have shown that PCBP} regulates 
the MOR gene expression by binding to a single stranded element located in the proximal 
promoter (Malik et aI., 2006, Rivera-Gines et al., 2006). PCBPI also participates in regulation of 
eIF4E and the androgen receptor (Lynch et aI., 2005, Cloke et aI., 2010). In HepG2 cells PCBPI 
acts a negative regulator of hyaluronic acid receptor (CD44) variants and loss of PCBPI in 
human hepatic tumor contributes to the fonnation of a metastatic phenotype (Zhang et aL, 2010). 
In addition, hnRNP K and PCBP1I2 are involved in the transcriptional silencing of 15­
lipoxygenase (LOX) mRNA expression, shown in Fig. 2B. The translational silencing of LOX 
mRNA is associated with fonnation of a RNP complex at a conserved CU-rich repeat motif 
called DICE (differentiation control element) located within the 3' UTR. In this function as a 
transcriptional regulator, hnRNP K and PCBPI proteins block the assembly of 60S and 40S 
ribosome units necessary for the complex at the initiation site AUG (Ostareck-Iederer et aI., 
1998). 
PCBPs have been associated in a wide range of posttranscriptional controls; one of the 
studies has shown PCBPI to be involved in mRNA stabilization of human a-globulin as shown 
in Fig. 2A (Chkheidze et aI., 1999). Binding ofPCBP2 to the tyrosine hydroxylase (TH) mRNA 
3'-UTR domain has been shown to regulate the interaction with its cognate polypyrimidine 
binding site. This increased interaction plays a role in the activation ofTH mRNA translation by 
cyclic AMP (cAMP) in dopaminergic neurons (Xu et aI., 2009). In cirrhotic liver, the hepatic 
12 

stellate cells (HSC) are the primary cells responsible for the dramatic increase in the synthesis of 
type I collagen. PCBP} is involved in the activation and stabilization of collagen a-I mRNA by 
binding to the C-rich sequence in its 3' UTR region (Stefanovic et al., 1997). 
In addition to its role in transcriptional and posttranslational regulation, PCBPI also acts 
as translational enhancer where PCBPl and PCBP2 interacts with picornaviral RNA structures 
and are known to regulate the viral genome translation and replication as shown in Fig. 2C 
(Zhang et al., 2007). The formation of an RNP complex containing the polio virus protein 
requires PCBP to promote RNA replication, suggesting a different role of PCBP (Andino et al., 
1990). In HeLa cell extracts binding of PCBP2 to stem-loop IV within the central region of the 
internal ribosome entry site (IRES) is essential for efficient poliovirus translation (Blyn et aI., 
1996; Gamarnik and Andino, 1997). In addition to their roles in mRNA stability and translational 
controls, the peBPs appear to have diverse functions in the regulation of transcriptional 
activation. hnRNP K has aspecific binding site on the SV40 early promoter (Gaillard et al.,1994) 
and in the pyrimidine-rich strand of the CT element in the promoter of human c-myc gene, as 
shown in Fig. 2D (Tomonaga and Levens, 1996). 
A study has shown that PCBP3 functions as a repressor, dependent on binding to single-
stranded and double-stranded poly (C) sequences (Kang et al., 2012). PCBP4 also known as 
MCG1 0 can suppress cell proliferation by inducing apoptosis and cell cycle arrest (Zhu and 
Chen, 2000). The structural variability of PCBP isoforms can contribute to the multiplicity of 
reported protein-protein interactions. The above reported functional roles of a protein can also be 
affected by other proteins in its environment and which may be mediated through variable 
protein-protein interactions. These roles of PCBPs could be mediated via protein interactions 
J 
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with several other proteins, hence identifying these interactions would benefit our 
underastanding of the effect they have on downstream cellular processes. 
t. Translatlollalenllanc.emellt 
ex:rx*·WusNonriral (via 3'011) PASP 
Ex: human «-globin ~IJ 
.......----'-0-4 
C"lidt nn 
B. Trans)ationalsJle1l,cmg D. Tr~sclil!t:ionalllcttvatioD 
Ex: 15-1ipoxyenase Ex: SV40 and o-myc 
~lI,_ 8bnRNPK 
..."""",___"""",C-.[l--G-An ---'0· r;=!: 
.~"DlCI!~ 
Adapted from Makeyev and Liebhaber, 2002 I 
Figure: 2 Examples of functions mediated by the PCBPs. ! 
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Four distinct examples of PCBP functions are shown in the above figure. A specific example is 
given for each of these indicated functions and described in the text. I 
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Known PCBP interacting proteins 
Yeast two hybrid experiments have shown that hnRNPK and PCPBs interact with 
different proteins. hnRNPK binds to the far upstream sequence element (FUSE) of the human c­
myc gene causing alterations in the DNA resulting in topology changes in the gene expression 
(Michelotti et aI., 1996). hnRNPK is known to dimerize and bind to several proteins from the Src 
family of tyrosine kinases and with protein kinase C (Tomonaga and Levens, 1995, Schullery et 
aI., 1999). Using the yeast two hybrid system, aCP-2 has been shown to interact with Y-box­
binding protein, splicing 908, and filamin (Funke et aI., 1996, Kim et aI., 2000, Oamarnik and 
Andino, 1997, Kim et aI., 2000). The N-tenninal of aCP-2 including two exons after the second 
KH domain is required for both homo-dimerization and interaction with hnRNP I, K, and L (Kim 
et aI., 2000). 
General importance 0/protein-protein interactions 
In order to understand the multifunctional role ofPCBPI , it is important to study protein 
interactions between PCBPl and its interacting protein partners. Within a cell, proteins interact 
amongst each other, phospholipids, metabolites and nucleic acids via different domains. 
Structural differences in different proteins playa vital role in mediating their interactions and the 
downstream cellular effects of the interaction complex. Studying how the interaction takes place 
in vivo will help us understand how various intracellular processes are regulated. 
Several examples of how various protein interactions regulate biological processes are 
explained below. During mitosis, appropriate assembly and constriction of the acto-myosin 
based ring is important for the final separation of the two daughter cells' which is coordinated by 
15 I 
the small GTPase, Rho. This contractile ring assembly requires the physical interaction of 
structural proteins like microtubuIes of the central spindle, motor proteins and Rho activators 
(Ebrahimi and Gregory, 2011). The Lin, lsI & Mec (LIM) are protein structural domains with 
two characteristic zinc finger motifs, these LIM domains interact via its zinc finger motifs with 
proteins within the nucleus, cytoplasm and can shuttle between the compartments. In one of the 
nuclear LIM proteins, the LIM homeodomain protein is known to regulate functions in cell 
lineage determination and pattern formation during animal development (Dawid et aI., 1998). 
The Src homology 2 (SH2) and Src homology 3 (SH3) domains belong to the Src-homology 
(SH) domain family and are involved in molecular interactions and intracellular signal 
transduction processes. The SH2 domain binds tightly to phosphorylated tyrosine residues and 
SH3 domain mediates its protein-protein interactions through recognition of specific proline-rich 
sequences (Pawson et aI., 2001). 
Another important protein is the insulin receptor (IR); with the presence of two 
characteristic domains that dominate its interaction with other protein partners. Insulin receptor 
substrate (IRS-l) is responsible for transduction of insulin dependent signals by regulation of 
various processes like cellular growth and uptake of glucose. The presence of a pleckstrin 
homology (PH) domain at the N-terminal region followed by a phosphotyrosine binding (PTB) 
domain ensures selective substrate recognition and phosphorylation of the activated IR (Morris et 
aI., 1996). IRs possess multiple tyrosine phosphorylation motifs, located at the C-terminal which 
serve as the docking site for the SH2 domain containing signaling molecules, such as 
phosphatidylinositol 3-kinase (PI 3-kinase), Grb-2 adaptor protein, and SHP2 (SH2 containing 
phosphatase 2) tyrosine phosphatase, which in tum stimulates the activation of biochemical 
cascades that promotes metabolic and cellular response to insulin (Farhang-Fallah et aI., 2002). 
! 
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Thus, protein domains are crucial players in the protein interactions mediating cellular signal 
transduction. 
Rationale ofthis study 
peBP I plays a vital role in various biological processes, thus it is important to 
understand how this protein mediates its functions. The multi-functionality of peBPI can be 
mediated through protein-protein interactions, determining how it interacts with other proteins 
will help understand its functional roles. The aim of this study is to identify peBPI interacting 
protein from the human brain eDNA library, characterize the interaction and study the functional 
effect of this interaction in the neuronal NMB cells. 
I 
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I Materials and Methods 
\1:: 
Culturing neuroblastoma cells 
Approximately 106 neuroblastoma (NMB) cells (Baumhaker et aI., 1994) were grown in T75 
flasks with Roswell Park Memorial Institute Medium (RPMI) (Invitrogen, Carlsbad, CA, USA) 
supplemented with 10% fetal bovine serum along with 0.1 % penicillin and streptomycin and 
maintained in an incubator at 37°C with 5% CO2• 
Lowry assay 
Using bovine serum albumin (BSA) as a standard, protein concentrations were detennined using 
. a Lowry assay. Cellular Iysates were incubated at room temperature (Rn with solution C (1.8 
mM Na2C03, 98 mM NaOH, 0.95 mM sodium potassium tartrate, and 0.4 mM CuS04.5H20) for 
10 minutes and then further incubated with 1 N Folin Ciocalteu's Phenol reagent for 30 minutes. 
The absorbance of each sample was measured at 660 hm using a spectrophotometer. 
Concentration of the cellular Iysates was detennined using a standard curve. 
Nuclear extract preparation 
Nucleoplasmic extracts were prepared from cells using the method previously described (Lin et 
aI., 2008). Briefly, cells were seeded at density of approximately 106 cells in a petri dish, once 
confluency was reached; cells were then harvested using 0.1 % trypsin and washed with 
phosphate buffered saline (PBS). The following steps were performed at 4°C. Cells were 
resuspended in sucrose buffer (0.32 M sucrose, 3 mM CaCh, 2 mM magnesium acetate, 0.1 mM 
EDTA, 10 mM Tris-HCI, pH 8.0, I mM dithiothreitol (DTT), 0.5 mM PMSF and 0.5% NP-40 
detergent). The pellet containing nuclei was collected by microcentrifugation at 500 x g, and 
18 

washed with sucrose buffer without NP-40. The nuclei were resuspended in low salt buffer (20 
mM HEPES, pH 7.9, 25 % glycerol, 0.02 M KCI, 1.5 mM MgCh, 0.2 mM EDTA, 0.5 mM DTT, 
and 0.5 mM PMSF), then lysed by gently mixing with high salt buffer (20 mM HEPES, pH 7.9, 
25 % glycerol, 0.8 M KCI, 1.5 mM MgCh, 0.2 mM EDTA, 0.5 mM DTT, 1% NP-40 and 0.5 
mM PMSF), followed by diluent (2.5 volume of25 mM HEPES, pH 7.6, 25 % glycerol, 0.1 mM 
EDTA, 0.5 mM DTT and 0.5 mM PMSF). The chromatin DNA and its associated proteins were 
removed by microcentrifugation at 13,690 x g, and the supernatant which contained 
nucleoplasmic proteins was then ready for use. 
Co-immunoprecipitation assay 
Co-immunoprecipitation of endogenous RACKI and PCBPI was performed using untransfected 
NMB cells. Cells were grown in T75 flasks in RPMI medium, upon reaching 95% confluence 
approximately 106 cells were washed with serum free RPMI media, harvested with PBS -EDT A 
trypsin and pelleted by centrifuging at 1000 rpm for 5 minutes. Harvested cells were resuspended 
in 500 mt of water and lysed with 1% SDS, along with protease inhibitors phenylmethylsulfonyl 
fluoride (PMSF) 1 mM, pepstatin to J.1g1mL, aprotinin 1 J.1g1mL, and sodium vanadate at 1 J.1M. 
The protein concentration was determined by a Lowry protein assay. Cell lysate was pre-cleared 
with 20 J.1g of IgO beads for 30 minutes on a rotating platform at 4°C. After incubation the cell 
extracts were centrifuged at 2500 rpm for 30 seconds. The supernatant was incubated overnight 
with 2 J.1g of anti-PCBPI antibody or preimmune IgO serum (negative control) on a rotating 
platform at 4 0c. After incubation 20 J.11 of IgO agarose beads prewashed and resuspended in 
water (1: 1 ratio) were added and incubated for 2 hours on rotating platform at 4 0c. The cell 
extracts were washed three times with RIP A buffer (1 % NP40, 0.5% sodium deoxycholate, in 
PBS) and then separated by'SDS-PAOE, described below in detail. 
19 
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SDS PAGE and Western blot analysis 
Samples were separated on a 12% sodium dodecyl sulfate-polyacrylamide gel (SDS-PAGE) at 
150 Volts for 2 hours at RT and then transferred to polyvinylidene difluoride membrane (PVDF) 
(GE healthcare, WI). After a series of washes in 0.1 % and 0.3% TIBS (Tween-20 Tris Buffered 
Saline), the membrane was probed with antibodies for RACKI and PCBPI (Santa Cruz 
Biotechnology, CAl. The signals for RACK I (32 kDa) and PCBPI (38 kDa) were detected using 
an enhanced chemiluminescence detection system (GE Healthcare, WI). The images were 
captured using Molecular Dynamic imager system (GE Healthcare, WI). Antibodies used for 
Western blotting are described in the table below. 
Antibody Dilutions Species raised in Source 
RACK! 1:500 Mouse Santa Cruz 
Biotechnology 
PCBPI 1:2000 Goat Santa Cruz 
Biotechnology 
Table 1: List of' primary antibodies used for Western blotting and antibody labeling 
experiments. I 
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Immunofluorescence and confocal microscopy 
Cells were grown on covers lips at density of 106 per well and fixed with 4% formaldehyde 
freshly prepared from parafonnaldehyde. The cells were penneabilized using 0.3% Triton X·l 00 
(Sigma Aldrich, MO). Cells were then incubated with a blocking solution containing 2% BSA 
and 0.3% Triton X·I00 in PBS for 10 minutes at RT. After blocking, cells were incubated 
overnight with primary antibody for RACKI at 4°C (dilution 1:500) (Santa Cruz Biotechnology, 
CA) and then with Cy3 conjugated secondary antibody (dilution 1: 100) (Jackson 
Immunoresearch, PA), for 2 hours at RT. The cells were counterstained with 4', 6-diamidino-2· 
phenylindole (DAPI) (Invitrogen, CA). Coverslip with cells was placed on the slide containing 
anti·fade reagent (Vector Shield, CA) and sealed with nail polish. To check the specificity of 
fluorescent secondary antibody, cells were stained using the same protocol without the addition 
of the primary antibody. To check the specificity of primary antibody, experiments were 
repeated with RACK I monoclonal as well as polyc1onal antibodies. 
Confocal microscopy 
Above prepared slides with cells were imaged using an Olympus FLUOVIEW-1000 confocal 
laser scanning microscope. Cells on the slides were initially focused using the wide-field 
fluorescence imaging mode at lOX. After locating the cells, cells were imaged using the 40X and 
or 60X oil immersion objective lenses. Light exposure was limited in order to avoid photo­
bleaching of the fluorescent dyes, the reporter dyes are summarized in Table 2. The gain setting 
for each detector was kept constant at IX. Cells were viewed in X and Y dimensions first and 
the confocal image stacks (Z-optical sections) were collected using preset Z dimensions which 
covered the entire cell. 
\ 
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Dye Excitation (nm) Emission (nm) 
DAPI (labeling nuclei) 358 461 
Cy3 (Secondary Antibody) 554 568 
Table 2: Excitation and emission wavelengtbs of dyes utilized in confocal microscope. 
•
t 
\ 
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Cloning ofRACK} deletion constructs 
Twelve deletion constructs were designed; six deletion constructs of RACKl 150-316 amino 
acids were constructed via deletion of residues from the N terminus of the fragment, sequentially 
deleting individual WD domains (McCahill et aI., 2002). The remaining six constructs were 
constructed, each comprised of an individual WD domain (McCahill et aI., 2002). 
I 
Construct Primer sequence 
WDI 5'-ACTGAGCAGATGACCCTT-3' 
WD2-7 5'-GAGACCAACTATGGA-3' 
WD3-7 5'-ACCACCACGGGCGA-3' 
WD4-7 5'-GTGCAAATACACTGT-3' 
WD5-7 5'-TGCAAGCTGAAGACC-3' 
WD6-7 5'·AAACACCTTTACACGCTA·3' 
WD7 5'-AAGCAAGAAG-3' 
WDIR 5'·ACCTTTGACTGGTCCCTAATC-3' 
WD2R 5'·GCGG AGACCCTAGAGTGTATC-3' 
WD3R 5'-TCTGCCGGITGTCAGAGGAGAAGG-3' 
WD4R 5'-CATACCTTGGACCGAA TC-3' 
WD5R 5'·CGGTACAATACCCTAGAGATC-3' 
WD6R 5'·TTCATCTACAATGATCTTTCCCTCATC-3' 
WD7R 5' -TGGT AACCGTGTGCGA TCCATAGTTTATC-3' 
[ 
[

Table 3: List of primers used in PCR to generate the RACKl constructs 
I
~ 
f 
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Amplified inserts were cloned into the pCRl.I vector (Invitrogen, CA) via EcoRI site and 
subcloned into pTRG vector (Agilent Technologies, CA) via SpeI and NotI site. Insert orientation 
was determined via restriction enzyme analysis and confirmed by DNA sequencing. 
Bacterial transformation 
JMI09 competent cells (Invitrogen, CA) were used for bacterial transformation according to 
manufacturer's protocol. Briefly, cells were incubated with 50 ng of plasmid on ice for 30 min. 
After incubation, cells were heat shocked at 42°C and then placed on ice for 2 min. Luria Broth 
(LB) media was added and cells were incubated at 37°C with shaking at 225 rpm for 60 min. 
The resultant transformants were plated on LB media containing 10 mg/ml of ampicillin as 
selection marker and incubated overnight at 37°C. 
Small scale plasmid purification 
Plasmids were extracted from cultures using a Qiaprep Miniprep Kit from Qiagen. Cultures were 
centrifuged and pellets were resuspended in re-suspension buffer PI (50 mM glucose, 10 mM 
EDTA, pH 8.5, 25 mM Tris HCI, pH 8). Resuspended cells were lysed using lysis buffer P2 (0.2 
M NaOH, 1% SDS), and then neutralized by adding neutralizing buffer N3 (5 M potassium 
acetate, glacial acetic acid). The plasm ids were separated by centrifugation and applied to 
Qiaprep spin column and washed with washing buffer PB and PE. The plasmids were then eluted 
using elution buffer EB (10 mM Tris HCI, 1 mM EDTA, and pH 8.4). 
Large scale plasmid purification 
Bacterial cultures were grown overnight at 37 OC with shaking at 225 rpm. The plasmids were 
extracted using a Qiagen Plasmid Maxi prep Kit (Qiagen, CA). Bacterial cultures were harvested 
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by centrifugation at 6000 x g and the pellet was resuspended in 10 mL ofre-suspension buffer PI 
(50 mM glucose, 10 mM EOTA, pH 8.5, 25 mM Tris HCI, pH 8). The bacterial suspension was 
then lysed by adding 10 mL of lysis buffer P2 (0.2 M NaOH, 1% SOS), which was further 
neutralized by adding 10 mL of neutralizing buffer P3 (5 M potassium acetate, glacial acetic 
acid). The mixture was centrifuged at 15,000 rpm for 30 min. The supernatant was applied to a 
Qiagen-tip column, which was then washed with washing buffer QC (I.O M NaCl, 50 mM 
MOPS, pH 7.0, 15% isopropanol). The plasmid was eluted using elution buffer QF (1.25 M 
NaCI, 50 mM Tris-CI, pH 8.5, 15% isopropanol), and was precipitated using isopropanol 
precipitation method. 
Bacteria two-hybrid screening 
XLI-Blue MRF' Kan strain of competent cells was purchased from Agilent Technologies, CA. 
According to the manufacturer's protocol, competent cells were incubated with 1.7 III of p­
mercaptoethanol on ice for 10 min, swirling every 2 min. Individual deletion domain construct 
(Target) plus the bait containing full length PCBPI were incubated with competent cell mixture 
and placed on ice for 30 min. Cells were subjected to heat shock reaction at 42°C and then 
incubated on ice for 2 min. SOC media (20 g tryptone, 5 g of yeast extract, 0.5 g NaCI, I M 
MgCh, I M MgS04, 2 M glucose) was added to the cells, which were then incubated at 37°C, 
with shaking at 225 rpm for 90 min. Cells were collected and washed with M9+ dropout broth 
(lOX M9 salts, M9 media additives (0.2% glucose, 0.02 mM adenine HCL, lOX His dropout 
amino acid supplement, 1M MgS04, 1 mM thiamine HCL, 0.1 mM ZnS04, 0.1 mM CaCb, 0.05 
mM IPTG» and then resuspended in M9 minimal salts broth with dropout minus histidine (M9+ 
His-dropout broth). Cells were incubated at 37°C with shaking at 225 rpm for 2 hours and then 
plated on agar plates containing the four selection markers; 0.5 ml of 25 mg/ml chloramphenicol, 
! 
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0.5 ml of 12.5 mg/ml tetracycline, 2.5 ml of 1 M 3-AT (dissolved in OMSO) and 0.5 ml of 12.5 
mg/ml streptomycin incubated at 37°C. The surviving clones were further verified using X-gal 
screening. 
RNA isolation and RT-PCR 
Total RNA from the cells was extracted using Tri-reagent (Invitrogen, CA) first and then with 
chloroform. The mixture was subjected to centrifugation at 12000 x g for 5 min at 4°C. The top 
phase containing total RNA was separated and RNA was precipitated using 100% molecular 
biology grade isopropanol (Sigma Aldrich, MO) at RT followed by centrifugation at 12000 x g 
for 15 min. The RNA pellet was washed with 70% ethanol and dissolved in Oiethyl 
pyrocarbonate (DE PC) treated water. RNA concentration was determined by using UV 
spectrophotometer and calculated by formula 00 260 X 50 Ilg/ ml. First strand cDNA was 
synthesized using 5 Ilg of total RNA using the random primer, in the presence of 200 units of 
reverse transcriptase. Amplification was performed for 50 min at 37°C and 15 min at 70 °C. 
PCR amplification of cDNA was performed for 1 min at 95°C, 35 sat 68°C, and 40 s at 72 °c 
for 32 cycles. 
Agarose gel electrophoresis 
The PCR products were analyzed by running on a 2% agarose gel containing 0.5 Ilg/ml of \ 
ethidium bromide, separated at 135 volts for 30 min. The gel was then imaged using Alpha I
t 
fimager gel doc under UV elimination (Alpha Innotech Corporation, CA) 
I 
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Transient transfection and luciferase Reporter gene assay 
NMB cells were seeded at densities 106 per well in 6-well culture plates (Coming, NY). After 
twenty-four hours cells were transfected using 1:2 ratio of DNA to lipofectamine reagent 
according to manufacturer's protocol (Invitrogen, CA). RACK1-PcDNA3 plasmid was used in 
three different concentrations 0.2 Ilg, 0.5 Ilg and 11lg along with Pg13-MOR plasmid at 0.5 Ilg· 
After forty-eight hours, cells were washed and incubated in RPMI 1640 medium supplemented 
with 10% fetal bovine serum. After seventy-two hours, the cells were harvested and lysed with 
the reporter lysis buffer (Promega, WI). The cell lysates were subjected to luciferase assay using 
a luciferase assay system (Promega, WI), and the activity was measured as relative light units 
(RLU) using a luminometer (Berthold). A Lowry assay was performed to determine 
concentration of protein present in the lysates and the data was normalized with the amount of 
protein. 
SiRNA transfection and whole cell preparation 
NMB cells were seeded at densities 106 per well in 6-well culture plates (Corning, NY) and then 
transfected with RACK1 siRNA using lipofectamine RNAimax according to manufacturer's 
protocol (Invitrogen, CA). The amount of lipofectamine was calculated using the manufacturer's 
recommendation using 1: 1 RNA to lipofectamine ratio. RACK 1 siRNA was used at three 
different concentrations 50 nM, 100 nM and 200 nM. After forty-eight hours, the cells were 
washed and incubated in RPMI 1640 medium supplemented with 10% fetal bovine serum. After 
seventy-two hours, the cells were harvested using 0.1 % trypsin by centrifugation at RT for 5 min 
at 1000 x g. The cell pellet was resuspended in 0.2 ml of 25 mM HEPES (NaCI 115 mM, eaCh 
,I 
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1.2 mM, MgCh, K2HP04 2.4 mM, PH 7.4). The harvested cells were used for binding 
experiments explained in detail below. 
Competition opioid hinding assay 
Cells were incubated for 10 min at RT with labeled eH] diprenorphine ligand at 2 nM 
concentration in the presence or absence of 1 IlM unlabeled ligand CTAP, in 25 mM HEPES (pH 
7.4). The two other receptor subtypes were blocked with subtype selective ligands (S) DADLE 
(D-Ala2, D-Leu5)-Enkephalin and (K) U50488 at concentrations of 1 IlM. After incubation with 
ligands the reaction was terminated by filtration on GFIB filters, the filters were washed two 
times with 7% polyethylene glycol (pEG) in HEPES buffer precooled at 4 °C and allowed to 
stand with Scintiverse-BD scintillation fluid (Fisher, PA) for 1 hour at 22-25 °C before counting 
with a scintillation counter (Perkin Elmer, MA). A Lowry assay was performed to determine the 
protein concentration in the control cell lysate and siRNA transfected cell lysate. Data was 
normalized using the amount of protein present in the control lysate. 
I 
Statistical analysis f 
Values are reported as mean ± SE from at least three independent experiments. Statistical I 
significance was determined using Student's paired t test. f 
Data quantification 
f 
Western blot and RT-PCR data was quantified using Image Quant software (GE Healthcare, 
WI). I 
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Results 
Identification ofPCBPI-interacting protein using bacteria two hybrid system 
Human brain cDNA library (Agilent Technologies, CA) was screened using bacteria two 
hybrid system to identify a PCBPI interacting protein. Full length PCBPI was cloned into pBT 
vector (PCBP-pBT) and human cDNA library was cloned in to the pTRG vector as shown in Fig. 
1, both the plasm ids were cotransformed and subjected to screening using high stringency media 
containing 3-amino-l,2,4-trizole (3-A T), streptomycin, chloramphenicol, tetracycline and 
streptomycin (explained in detail under materials and methods section, Page 24). One of the 
positive clones that grew on the media screening contained 1 kilobase of cDNA insert. The 
positive clone was subjected to DNA sequencing and NCBr blast analysis and was identified as 
RACKl. I 
In order to validate the interaction between RACKI and PCBPI, RACKl was cloned in f I 
the pTRG vector of the two hybrid system. PCBPI-pBT and RACKl-pTRG were cotransformed I 
I 
~. 
and were subjected to screening by ability to grow at 37 °C on high stringency media (explained 
in detail under materials and methods section, Page 24). All the clones subjected to high f 
I
stringency screening grew on the screening media. The surviving clones under high stringency l 
selection were reproduced and verified to validate the interaction between RACK I and PCBPI. I 
Thus, bacteria two hybrid screening results have showed that PCBPI and RACKl interact with Ieach other. ! 
I 
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Figure 3: Screening using bacteria two bybrid system 
Schematic of the bacteria two hybrid system where PCBP 1 (bait) was cloned in to the pBT 
vector and human brain cDNA library (target) was cloned in to the pTRG vector. When the bait 
and target protein interact, they recruit and stabilize the binding of RNA polymerase at the 
promoter and activate the transcription of the HIS3 reporter gene which allows bacterial cells to 
grow on the media containing 3-A T. Thus, bacteria two hybrid system helps to identify the 
interacting protein from a cDNA library and also helps to characterize the interaction between a 
known protein pair. 
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RACKI physically interacts with PCBP 1 
In order to determine if the interaction between RACKl and PCBPI also occurs 
in the mammalian neuronal cells, the human neuroblastoma (NMB) cell model system was 
selected. PCBP! is expressed endogenously in the NMB cells (Lin et al., 2008). The endogenous 
expression of both RACK! and PCBPI was determined by subjecting NMB cell lysate to 
Western blot analysis. As shown in Fig. 4A, in lane I, a 38 kDa PCBPI protein was observed. 
The same blot was later probed with anti-RACK I antibody (lane 2) and a 32 kDa RACKI 
protein was also observed. Thus, results of Western blot analysis confirmed expression of both 
RACKI and PCBPI in the NMB cell system. 
Upon confirmation of endogenous expression of both RACKI and PCBP! proteins, co­
immunoprecipitation assay was performed using the NMB cell lysate. An anti-PCBPl antibody 
was used to immunoprecipitate PCBPI from NMB cells prior to detection of RACK! by 
Western blotting. As shown in Fig. 4B, lane 2, a 38 kDa band, corresponding to PCBP} was 
observed successfully precipitating PCBPI and absent in the control lane I. Lane 3 consists of 
plain NMB lysate. The same blot was reprobed with anti-RACK I antibody without stripping I 
PCBP} signal. As shown in Fig. 4C, lane 2, a 32 kDa band for RACK I was observed in the same 
lane as PCBPl and absent in the control lane, indicating that RACKI co-immunoprecipitated I 
with PCBP!. In summary, this data confirmed the physical interaction between RACK} and 
PCBP} in the human neuronal cells. ! 
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Figure 4: Co-immunoprecipitation of RACK1 and PCBPI 
(A) Results from Western blot showing endogenous expression of both proteins, PCBPI and 
RACKI in the NMB cells. The whole cell lysate from NMB cells was subjected to SDS-PAGE 
and analyzed with anti·PCBPI antibody showing a 38 kDa band for PCBPI (lane 1). The same 
blot was probed with anti-RACKl antibody showing a 32 kDa band for RACKI (lane 2) without 
stripping off PCBPI signal. (B) Co-immunoprecipitation of PCBPI and RACKI, whole cell 
lysates from NMB cells were incubated with anti-PCBPI Ab (lane 2) and anti- IgG (negative 
control lane 1). Lane 3, labeled as control lysate is whole cell lysate alone. The bound proteins 
were subjected to SDS-PAGE and then Western blot analysis using anti-PCB PI antibody. A 
38kDa band for PCBPI (lane 2) was observed, indicating that PCBPI was successfully 
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I 
immunoprecipitated. (C) The same blot was reprobed with anti-RACKl antibody without 
stripping the signal of PCBPl, showed that anti-PCBPl Ab successfully precipitates RACKl 1 
32 kDa band indicated (Lane 2), and the 32 kDa band was absent in the control lane (lane I). 
Intracellular localization ofRACK] 
The intracellular distribution of RACKl was investigated by indirect 
immunofluorescence staining followed by confocal laser-scanning microscopy and Western blot 
analysis. Equal amounts of the whole cell lysate and the nuclear extract lysate were subjected to 
Western blotting and the RACKl protein was detected using anti-RACKl antibody. As shown in 
Fig. 5A, RACK I was localized both in the nucleus and cytoplasm. The whole cell lysate 
contained higher amount of RACK 1 protein than the nuclear extract. The quantified data in form 
of histograms are shown in Fig. 5B; RACK1 signal in whole cell lysate is defined as 100%. The 
data from the histograms showed that RACK 1 is expressed at higher levels in the cytoplasm 
when compared to the nucleus. Cellular distribution of RACKI was further studied using 
antibody labeling experiments. 
Neuronal cells were labeled with anti-RACK! antibody which was detected using Cy3­
conjugated anti-IgG secondary antibody. RACK! has a prominent cytosolic distribution with a 
diffuse nuclear distribution Fig. 5C (I). The nucleus was counterstained with DAPI as shown in 
Fig. 5C (II) and the merged images from both Cy3 and DAPI channels are shown in Fig. 5C 
(III). Combined results of Western blot analysis and antibody labeling experiment show that 
RACK! expression levels were higher in the cytoplasm when compared to the nucleus. Thus, 
RACK! localization in NMB cells was predominantly higher in the cytoplasm when compared 
to the nucleus. I 
f 
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Figure 5: Intracellular localization orRACKl in NMB cells 
(A) Results from Western blot analysis of RACKI comparing whole cell lysate and nuclear 
extract. A 32 kDa band for RACK 1 was found in the nuclear extract, suggesting its nuclear 
localization. RACK 1 has prominent cytosolic distribution when compared to its nuclear 
distribution evident from Western blot analysis. (B) Quantified histograms of three different 
I 
1Western blots shown here, the amount of RACK 1 from whole cell lysate was defined as 100 %. 
The histograms are presented as mean ±SE. "*,, indicates p < 0.01 (Student'S paired t-test). (C) 
Immunofluorescence staining showing RACK 1 distribution in the cytosol as well as nucleoplasm 
(C-I). Nucleus was stained with DAPI (C-II) and the merged image (C-III) shows that, RACKI 
has prominent cytosolic distribution as compared to nuclear distribution. 
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Cellular localization ofRACKI-PCBPI interaction 
The physical interaction between PCBPl and RACKl was confinned by the Co­
immunoprecipitation experiment shown in Fig. 3. The data from antibody labeling experiment I 
has demonstrated that RACKl is localized both in the nucleus and the cytoplasm Fig. SA. The 
interaction between RACKI and PCBPI was further examined. A co-immunoprecipitation 
experiment using anti-PCBPI antibody was performed to compare nuclear extract and whole cell 
lysate. As shown in the Fig. 6A, a 38 kDa band corresponding to PCBPl was observed in the 
whole cell lysate. The same blot was probed with anti-RACKl antibody shown in Fig. 6B lane 2; 
a 32 kDa band of RACKl was also seen. Thus, the PCBPl antibody successfully precipitated 
PCBPI and its interacting protein RACKl from the whole cell lysate. Similarly a co­
immunoprecipitation experiment using the anti-PCBPI antibody was perfonned using the 
nuclear extract as shown in the Fig. 6C. A 38 kDa band for PCBPI was observed in the nuclear 
extract. The same blot was probed with anti-RACKI antibody. Here however, the 32 kDa band 
for RACKI was not observed. Results of the co-immunoprecipitation experiments thus indicate 
that, PCBPI and RACKI interact in the cytosol but this interaction does not occur within the 
, 
nucleus. I 
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Figure 6: Co-immunoprecipitaion of RACK1 and PCBPI using NMB lysate 
(A) Results from Western blot analysis of co-immunoprecipitation assay using whole cell lysate. 
Whole cell lysate from NMB cells was incubated with anti·PCBPl antibody (lane 2) and non­
specific antibody (lane l, negative control). Lane 3 labeled as control lysate is whole cell lysate 
alone. The Western blot analysis has shown to successfully precipitate PCBPI (B) The same blot 
was probed with anti-RACKl antibody without stripping the PCBPI signal. The Western blot 
analysis shows that anti-PCBPI antibody successfully co-precipitates RACKI (lane 2, arrow) I
f
whereas no RACKl was detected in the negative control IgG (lanel). (C) Nuclear extract from 
I 
J 
the NMB cells was incubated with anti·PCBPl antibody (labeled NE) and non-specific anti-IgG 
antibody (labeled as C, negative control). Lane 3 labeled as cell lysate is the nuclear extract 
lysate alone. Western blot analysis using anti-PCBPI antibody has shown to successfully t 
precipitate PCBPl from the NMB cell lysate (38 kDa band, arrow). (D) The same blot was then 
probed with anti-RACKl antibody without stripping the PCBPI signal. The Western blot 
36 
analysis has shown that anti-PCBPl antibody did not co-precipitate RACKl (NE) and no 
RACKI was also detected in the IgG (C negative control) lane. 
Minimal domain mapping ofPCBP} -RACK} interaction 
The presence of seven WD-40 repeats in RACK 1 has implicated its role in protein-
protein interactions (Imai et aI., 2009). The domain required for the interaction between PCBPl 
and RACK I was mapped by deleting the WD domains from the N terminus of RACK I. The six 
RACKI deletion plasmids were constructed using polymerase chain reaction (PCR), and PCR 
products were cloned into pCRl.l cloning vector. The positive clones containing the PCR 
products were screened by restriction enzyme digests followed by agarose gel electrophoretic 
analysis (described in detail under materials and method section page 25). The plasmids 
containing the PCR products were then subjected to DNA sequencing. Restriction enzyme 
digests were run on agarose gel as shown in the Fig. 7. The predicted size PCR products for each 
of the six constructs are shown by an arrow. In summary .. using PCR cloning method RACKI 
WD domain deletion constructs were successfully generated. 
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Figure 7: Cloning ofRACKl WD domain deletion construct by PCR 
Agarose gel electrophoresis of cloned sequentially truncated six RACKl (WD2-7, 3-7,4-7,5-7, 
6-7 and 7) constructs into the pCR2.1 vector. The PCR products cloned into the pCR2.1 vector 
were screened using EcoRI restriction enzyme. The digested products were run on 2% agarose 
gel containing 0.5 ~g/mt of ethidium bromide. The insert band of correct size is indicated by an 
arrow and the band seen at much higher size represents the cut pCR2.1 vector. On each gel 
picture above, lOa bp ladder was used and the positive clones were confirmed by DNA 
sequencing. 
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Subcloning ofthe WD deletion domains into the Bacteria two-hybrid vector system 
The six sequentially truncated RACKl WD domain constructs in pCR 2.1 vector were 
grown and then subcloned into the pTRG vector of the bacteria two-hybrid system. The WD 
deletion constructs were cloned into the Not! and SpeI site, via restriction enzyme digestion. The 
digested product was ligated with the pTRG vector, transformed in the bacterial cells and further 
screened. To ensure positive clones contained the specific WD domain insert, NotI and SpeI 
digests were performed followed by agarose gel electrophoresis. As shown in the Fig. 6, an insert 
band ofcorrect size is indicated by an arrow and the band seen at much higher size represents the 
cut pTRG vector. The positive clones were sequenced to check for sequence specificity. In 
summary, RACKl truncated constructs were successfully subcloned using pTRG vector into the 
bacteria two hybrid system. 
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Figure 8: Subcloning of RACKl WD deletion constructs into the pTRG vector I 
~ 
I 
Agarose gel electrophoresis of subcloned RACK} truncated constructs into pTRG vector. PCR 
products subcloned into the pTRG vector were screened using Not! and SpeI restriction enzymes. 
The digested products were run on 2% agarose gel containing 0.5 J.lglml of ethidium bromide. 
The insert band of correct size is indicated by an arrow and the band seen at much higher size 
represents the cut pTRG vector. On each gel picture above, } 00 bp ladder was used and the 
positive clones were confirmed by DNA sequencing. I 
f 
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Mapping the interaction site using the bacteria II hybrid system 
The pTRG subc10ned RACKI truncated constructs were used to test for their ability to 
interact with full length PCBPl, using the bacteria two-hybrid system screening with three 
selective markers, chloramphenicol, tetracycline and 3-AT. Colonies that grew on media 
containing three markers were streaked onto higher stringency media containing four selective 
markers: 3-AT, chloramphenicol, tetracycline and streptomycin (described in detail under 
materials and method section page 24). These selection media were selective for both the 
plasmids as well as for the interaction between the proteins encoded by both the plasmids. As 
shown in the Fig. 9, among all the constructs of RACKl, the strongest interaction between 
PCBPI and RACKI was observed with full length RACKl. Deletion ofWDl domain (WD 2-7) I
t 
and WD 2 (WD 3-7) resulted in decrease in the interaction and further deletion of WD4 (WD 5- i 
7) showed a significant decrease in the interaction. Deletion of WD 1-5 (WD 6-7) has shown to 
have no significant effect on interaction as compared to that of the WD 5-7. Importantly, WD7 
solely encoding the seventh WD-40 domain showed strongest interaction with PCBPl, 
comparable to that of full length RACKl. These results implicate that the WD7 domain is the ! 
f 
key domain which bestows RACKI the ability to interact with PCBPI. To ensure that only WD 
t7 is the key domain responsible for the RACKl-PCBPl interaction and the interaction is not 
dependent on the other WD domains of RACKl, six clones containing individual WD domains I 
,
[ 
were constructed and tested explained in the Fig.ll. 
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Figure 9: Minimal Domain Mapping of PCBPI-RACK1 interaction 
Listed above are deletion constructs names under construct column and corresponding domains 
on the right. RACKI deletion constructs were cotransformed with full length PCBPI using the 
. bacteria two hybrid system. Resultant transformants Were subjected to selection media 
containing tetracycline, chloramphenicol, 3-AT and streptomycin. Empty vector (pBT) was used 
as a negative control. The interaction between PCBPI and RACKI was assessed by 'ability to 
grow' (indicated by + sign), with the growth of full length RACKl and PCBPI indicated as 
(++++). The growth results shown here represent three independent experiments. Among all the 
six RACK! constructs, WD7 has shown the strongest growth and thus ability to interact with 
PCBPI. 
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Cloning ofindividual WD domain ofRACKl 
Six RACKl constructs containing each of the domains, WDl-6 were cloned using PCR 
cloning method. PCR was performed and PCR products were ligated with pCR2.1 vector, 
transformed in the bacterial cells and further screened. The positive clones containing the PCR 
products were screened by EcoRI restriction enzyme digests followed by gel electrophoresis 
analysis shown in the Fig. 10. The plasmids containing the PCR products were then subjected to 
DNA sequencing. PCR products for each of the six constructs below are indicated by an arrow 
and the band seen at much higher size is the cut pCR2.l vector. In summary, using PCR cloning, 
individual WD domain constructs ofRACK 1 were successfully generated. 
,I 
f 
43 

 
WDI WD4 
147bp 135bp 
WD2 
136bp 
WD3 WD6 

129bp 167bp 
Figure 10: Cloning of individual WD domains of RACK1 
Agarose gel electrophoresis of six RACK 1 (WD 1. WD2, WD3, WD4. WDS and WD6) deletion 
constructs cloned in the pCR 2.1 vector. The constructs were generated by PCR and products 
cloned into the pCR2.l vector were screened using EeoR! restriction enzyme. The digested 
products were run on 2% agarose gel containing O.S J.lglml of ethidium bromide. The insert band 
of correct size is indicated by an arrow and the band seen at much higher size represents the cut 
pCR2.1 vector. On each gel picture above, 100 bp ladder was used and the positive clones were 
confirmed by DNA sequencing. 
44 

I 

I

t 
, 
f 
\ 

Subcloning ofIndividual WD domains in the pTRG vector 
The six WD constructs in the pCR2.l vector were grown and subcloned into the pTRG 
vector of the bacteria two·hybrid system. The WD deletion constructs were cloned into the Noll 
and SpeI sites, via restriction enzyme digestion. The digested product was ligated with the pTRG 
vector, transformed in the bacterial cells and screened. To ensure a positive clone contained the 
respective WD domain insert, NotI and SpeI digests were performed followed by agarose gel 
electrophoresis. As shown in Fig. 11, an insert band ofcorrect size is indicated by an arrow and a 
band seen at much higher size represents the cut pTRG vector. The positive clones were 
subjected to DNA sequencing. In summary, using the bacteria two hybrid system RACKl 
domain deletion constructs were successfully cloned in to the pTRG vector. 
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Figure 11: Subcloning ofIndividual WD domains in the pTRG vector 
Agarose gel electrophoresis of subcloned RACKl individual domain constructs into pTRG 
vector. PCR products cloned into the pTRG vector were screened using NotI and SpeI restriction 
enzymes. The digested products were run on 2% agarose gel containing 0.5 J.1g1ml of ethidium 
bromide. The insert band of correct size is indicated by an arrow and the band seen at much 
higher size represents the cut pTRG vector. On each gel picture above, 100 bp ladder was used 
and the positive clones were confirmed by DNA sequencing. 
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Testing the individual RACK} domains/or interaction with PCBP} 
Using the two-hybrid system, each plasmid containing individual WD domain was co­
transformed with pBT-PCBPI plasmid and screened under the high stringency selection media 
(described in details under materials and methods section page 24). The interaction capacity of 
the WD domains was evaluated by growth rate on screening media as compared to the full length 
RACKL The interaction with full length RACKI was defined as 100% and was the strongest 
among all constructs. As shown in Fig. 12, in addition to the WD7 domain, the WD2 and WD3 
domains of RACKI also displayed some ability to interact with PCBP!, but the growth was 
much reduced when compared to that of the WD7 domain, indicating a weaker interaction. The 
WD6 domain interacted very weakly and the remaining domains (WD 1, 4 and 5) did not show 
ability to interact with peBPl. Among all the domains, WD 7 alone has shown to possess the 
strongest ability to interact with PCBP!. Combined results from the screening of deletion WD 
constructs (Fig. 9) and the screening of the individual WD constructs (Fig. 12) have 
demonstrated that the WD7 domain of RACK! is crucial for the interaction with RACKI and 
PCBPI. 
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Figure 12: Testing the individual RACKI domains for interaction with PCBPI 
Listed above are deletion constructs names under construct column and corresponding domains 
on the right. RACKl deletion constructs were cotransformed with full length PCBPl using the 
bacteria two hybrid system. Resultant transformants were subjected to selection media 
containing tetracycline, chloramphenicol, 3-A T and streptomycin. Empty vector (pBT) was used 
as a negative control. The interaction between PCBPl and RACKl was assessed by 'ability to 
grow' (indicated by + sign), with the growth of full length RACKl and PCBPI indicated as 
(++++). The growth results shown here represent three independent experiments. Among all the 
7 RACKI constructs, WD7 has shown the strongest growth and thus ability to interact with 
PCBPI. 
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RACK 1 regulates the Mu opioid receptor (MOR) proltWter activity 
The data from co-immunoprecipitation experiments has shown that PCBPI and RACKI 
interact endogenously in the NMB cell system (Fig. 3). The functional effect of this interaction 
was further studied. Studies have shown PCBPI to regulate the MOR expression by binding to 
ssDNA element located in the proximal promoter (Malik et aI., 2006). Therefore, the effect of 
RACK 1 overexpression on human MOR (hMOR) gene expression in NMB cells was 
investigated. The RACKl cDNA was cloned into a mammalian expression vector pcDNA3 
resulting in the pcDNA3-RACKl plasmid. Luciferase reporter gene assay was then performed 
by cotransfection of 0.2, 0.5, and 1.0 Ilg concentrations ofpcDNA3-RACKI plasmid. The blank 
vector (pcDNA3) was used as a control, along with the luciferase reporter plasmid p357 
containing the hMOR promoter (Cook et aI., 2010). The luciferase assay was performed and data 
was normalized using the amount of the total protein present in each sample. The normalized 
activity of blank vector was defined as 100%. As shown in the Fig. 13, the reporter activity of 
hMOR decreased as the amount of RACKI overexpression increased. The quantified data has 
shown a 50% decrease in hMOR promoter activity in samples transfected with I Ilg ofRACKl 
plasmid when compared to control. These findings suggest that the interaction between RACKI 
and PCBPI has a functional effect on the hMOR promoter activity, which may influence the 
MOR gene expression. 
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Figure 13: RACK 1 regulates the Mu opioid (MOR) promoter activity 
Results from Luciferase reporter gene assay, NMB cells were transiently transfected either with 
pcDNA3-RACKl (textured bar) and pcDNA3.1 vector (Black bars as control) along with p357 
plasmid containing the human active MOR promoter in the luciferase reporter pGL3-basic 
vector. After forty-eight hours of transfection, the luciferase activity of the cell extracts was 
quantified using a luminometer and the activity of control (empty vector) without the RACKl 
plasmid was compared to the three different concentrations of RACKl plasmid co-transfected 
with plasmid containing hMOR promoter. Promoter activity of each construct was expressed as I 
n-fold activation of pGL3-basic plasmid activity. Histograms represent mean values of n-fold 
activation. In cells with RACKI overexpressionthe hMOR promoter activity was reduced in a Idose dependent manner from 20% with lowest concentration (0.2 J.lg) to 50% with highest I 
concentration (1 J.lg). The luciferase data was normalized using protein concentration present in 
each sample and the histograms represent mean ± SE from six different experiments. On.ly the 
• 
plus error bars are shown in the figure. "." indicates p < 0.01 (Student's paired t-test). I I 
I 
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Effect ofRACK1 siRNA knockdown on RACK1 expression levels 
To further confirm the regulatory effect shown in Fig. 13, RACKl-PCBPl interaction has 
shown to regulate hMOR gene expression, RACKl siRNA knockdown experiment was 
performed. Several concentrations (50, 100 and 200 nM) of RACKl siRNA were transfected 
into the NMB cells while mock transfected cells were used as control. Forty eight hours after 
transfection, total RNA was isolated and RT-PCR was performed using primers for RACK!. 
Human p-actin primers were included in every PCR reaction as an internal control. The use of 
increasing amount of RACKl siRNA has shown to decrease RACKl mRNA levels Fig. 14A. 
The amount of endogenous RACKl mRNA from the control cells was defined as 100% .The 
quantified histograms Fig. l4B, have shown a significant decrease in RACKl mRNA levels 
80% with lowest concentration (50 nM) to 50% with highest concentration (200 nM) of RACK 1 
siRNA. Combined, these results have demonstrated that RACKl siRNA successfully knocked 
down the RACK 1 mRNA levels in the NMB cells. 
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Figure 14: Knockdown of RACKI mRNA levels using RACK1 siRNA 
CA) Results from RT-PCR showing RACKI gene expression levels in NMB cells transfected 
with three different concentrations of RACK1 siRNA. The mock transfected cells were used as 
control and human p-actin specific primers were included in every PCR reaction (added at cycle 
12) as internal control for normalization. PCR products were analyzed on a 2% agarose gel 
containing 0.5 flg/ml of ethidium bromide and then quantified. (B) The normalized mRNA levels , 
from control were defined as 100% and the quantified data has shown to decrease the RACKI t 
mRNA levels in cells transfected with RACKI siRNA when compared to control. Shown here 
mRNA levels are presented as mean ± SE from six different experiments. Only the plus error 
bars are shown in the figure. ""''' indicates p < 0.01 (Student'S paired t-test). 
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Effect ofRACK siRNA on hMOR mRNA levels 
Since RACKI siRNA has shown to successfully knockdown RACKI mRNA levels (Fig. 14), 
effect of the RACKl siRNA on the hMOR gene expression was further studied. Three different 
concentrations of RACKl siRNA (50, 100,200 nM) were used for transfections and forty·eight 
hours after the transfection and RT-PCR using primers specific for hMOR gene was performed. 
As shown in Fig. I5A, significant increase in the endogenous hMOR mRNA levels was observed 
in a dose dependent manner with increasing amounts of RACK 1 siRNA. The quantified data of 
hMOR mRNA levels in the form of histograms are shown in Fig. I5B. In each RT-PCR reaction 
p·actin was used as an internal standard for data normalization and the amount ofhMOR mRNA 
from the control cells was defined as 100%. Collectively, data from luciferase assay (Fig. 13) 
and RACKI siRNA experiments (Fig. 15) have shown that RACKI negatively regulates hMOR 
gene expression. 
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Figure 15: Effect of RACKl siRNA on hMOR mRNA levels 
(A) Results of RT -PCR showing hMOR gene expression levels in NMB cells transfected with 
three different concentrations of RACKl siRNA. The mock transfected cells were used as 
control and human ~-actin specific primers were included in every PCR reaction (added at cycle 
12) as internal control for normalization. PCR products were analyzed on a 2 % agarose gel I 

containing 0.5 IJg/ml of ethidium bromide and then quantified. (B) The normalized mRNA levels 
from control were defined as lOO% and the quantified data has shown increase in the hMOR I 

mRNA levels in cells transfected with RACKl siRNA when compared to control. Shown here I 

mRNA levels are presented as mean + SE from six different experiments. Only the plus error i 

bars are shown in the figure. "*,, indicates p < 0.01 (Student's paired t-test). 
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Effect ofRACK} knockdown on RACK} protein level 
To further investigate whether changes in RACKI mRNA also reduces RACKl protein 
levels, NMB cells were transfected with 200 nM of RACK 1 siRNA and Western blot analysis of 
these transfected sample was performed. As there was no significant change in RACK 1 protein 
levels forty-eight hours after transfection (Fig. 16A), the changes in the RACKl mRNA and 
protein levels were studied after seventy-two hours. As shown in Fig. 16B, RACKI mRNA 
levels remained low as compared to the control. After seventy-two hours oftransfection Western 
blot analysis was performed as shown in Fig. 16C, the endogenous RACKl protein level were 
significantly reduced. Anti-~-actin antibody was used as an internal standard for normalization. 
The quantified data of the Western blot analysis Fig. 16D, has shown decrease in the RACKl 
protein levels (approximately 50%) when compared to the control (defined as 100%). These 
results demonstrated that the RACK 1 protein levels were significantly reduced after seventy-two 
hours of transfection while there was no significant decrease in the RACKI protein levels after 
forty-eight hours oftransfection with RACKI siRNA. 
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Figure 16: Effect of RACK1 siRNA on RACK1 protein level 
(A) Results from Western blot analysis of RACK! protein levels after forty eight hours post 

transfection using anti-RACK! antibody along with human ~-actin antibody as an internal 

standard. There is no significant change in amount of RACKl protein in siRNA transfected 

sample when compared to the control. (B) Results from RT-PCR of RACKl mRNA expression 

after seventy-two hours of transfection of NMB cells with 200 nM RACK! siRNA and mock 

transfected cells as control. There was significant decrease in the RACK! mRNA levels. (C) 

Results from Western blot analysis of RACK! protein levels after seventy-two hours of 

transfection using anti-RACK! antibody along with human ~-actin antibody as an internal 

standard for normalization purpose. (D) The normalized protein levels of RACKl protein from 

the control were defined as lOO %. There is decrease in RACKI protein levels approximately 

50% when compared to control shown by the quantified histograms. The data shown in 
 f }
, , quantified histograms are presented as mean ± SE from six different experiments. Only the plus 
(
error bars are shown in the figure. "*,, indicates p < 0.01 (Student's paired t-test). 
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ElfectofRACKl siRNA on PCBPl 
Interaction between RACKI and PCBPl has shown to have a functional effect on hMOR 
gene expression (Figs. 13 and 15). PCBP 1 has also been known to regulate hMOR gene 
expression (Cook et at, 2010). Thus, the effect of RACK I siRNA on PCBPI in NMB cells was 
further investigated. After seventy-two hours of transfection RT-PCR using primers specific to 
I 
I 
PCBPl was performed. There was no significant change in levels of PCBPl mRNA Fig. 17A, 
when compared to the control. ~-actin was used as an internal standard and the quantified PCBPI i 
mRNA levels are shown in Fig. 17B. The normalized PCBPI mRNA level from the control was 
defined as 100%. In cells transfected with RACKl siRNA no significant difference in PCBPI 
mRNA levels was observed. 
PCBP 1 protein levels were also examined by Western blot analysis using anti-PCBP I 
antibody and anti- ~-tubulin antibody was used as internal standard for data normalization. As I 
shown in Fig. 17C and 17D, there was no significant decrease in the PCBP 1 protein levels. I 
Combined, results from the RT-PCR and the Western blot analysis show that there is no 
I 
J 
significant effect on endogenous PCBPI mRNA and protein levels in cells transfected with 
RACK 1 siRNA. 
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Figure 17: Effect of RACK1 siRNA on PCBPI mRNA and protein levels. 
(A) Results 	 from RT-PCR analysis of PCBPI mRNA levels seventy-two hours after 
transfection with 200 nM RACKl siRNA and mock transfected cells as control. PCR 
products were analyzed on a 2% agarose gel electrophoresis. (B) Quantified histogram of 
the normalized PCBP 1 mRNA level from control was defined as lOO % and has shown 
no significant difference in PCBPl mRNA levels between control and RACKl siRNA 
transfected cells. (C) Results from Western blot analysis of PCBPl protein levels using 
anti-PCBPI antibody. Human P-Tubulin antibody was used as an internal standard for 
normalization purpose. (D) Quantified histogram of PCBP 1 protein levels has shown no 
significant difference in the PCBPI protein levels in cells transfected with RACK siRNA 
when compared to control. The histograms shown here are presented as mean ± SE from 
five different experiments. Only the plus error bars are shown in the figure. 
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Effect ofRACKl siRNA on the hMOR protein levels 
To further investigate whether changes in hMOR mRNA levels also had an effect on the 
hMOR protein levels, radiolabeled receptor binding experiments were performed. In cells 
transfected with RACK 1 siRNA an increase hMOR mRNA levels was observed Fig. 13A and 
13B. Thus, the effect of RACK I siRNA on hMOR mRNA and protein levels seventy-two hours 
after transfection was further investigated. After seventy two hours oftransfection with RACK! 
siRNA, the mRNA levels of hMOR were still elevated when compared to control (Fig. 18A) 
thus, the level of hMOR protein was further examined by radiolabeled receptor binding assay. 
The hMOR protein is a receptor which can bind to opioid ligand such as diprenorphine. Using 
radioisotope labeled 3H-diprenorphine, receptor binding assay was performed with I IlM CTAP 
as the competitive ligand. As NMB cells express all three opioid receptors, Il. 6, and K 
(Baumhaker et al.. 1994), the two sub-types (K and 6) receptors, were blocked using receptor 
subtype selective ligands DADLE (6) and U50488 (K) at a concentration of} IlM. Specific 
binding activity was calculated as count per minute (CPM)/mg of protein shown in Fig. 18B. 
where a significant increase in hMOR receptor binding in cells transfected with RACKl siRNA I 
I 
was observed when compared to control cells. Percent binding of receptor was also calculated as \ 
shown Fig. 18C, where specific binding from the control was defined as 100 % and the binding 
data was normalized for equivalent amount of protein present in control and siRNA transfected 
cells. Significant increase in the percent binding in cells transfected with RACKI siRNA was 
observed. As shown from the Fig. 18B and 18C, siRNA knockdown of RACK} has resulted in 
an increase of hMOR mRNA level and also resulted in increase of hMOR protein level at 
seventy two hours post transfection. In summary, RACK! knockdown decreases the endogenous 
\RACK! protein level, which results in increase in the endogenous hMOR mRNA and hMOR ! 
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protein levels in the NMB cells. This data supports the finding of the luciferase reporter gene 
assay (Fig. 13), that RACK 1 regulates the MOR expression levels by interacting with PCBPI. 
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Figure 18: Effect of RACKl knockdown on MOR protein level 
(A) Results from RT-PCR analysis showing hMOR mRNA levels seventy-two hours after 
transfection with RACKI siRNA, human ~-actin specific primers were included in every PCR 
reaction (added at cycle 12) as an internal standard. PCR products were separated and analyzed 
on a 2% agarose gel. Increase in hMOR mRNA levels in samples with RACK I knockdown 
when compared to the control mock transfected cells was seen (B) The hMOR protein levels 
were determined using competitive receptor binding experiments using radio labeled 3H_ 
diprenorphine .and I ~M CTAP as the competitive ligand. To block the other two (K and S) 
subtype receptor specific ligands DADLE (S) and U50488 (K) were used at concentration of I 
~M. Specific binding activity defined as CPM/mg protein was calculated and shown in form of 
. histograms. The data from specific binding activity as CPM/mg protein has shown increase the 
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binding in cells transfected with RACKI siRNA when compared to control. (C) Percent specific 
binding was also calculated where binding from the control was defined as 100% and the binding 
data was normalized for equivalent amount of protein present in control and siRNA transfected 
cells. Quantified histograms of receptor binding levels are presented as mean ± SE from three 
independent experiments. Only the plus error bars are shown in the figure. "*,, indicates p < 0.01 
(Student'S paired t-test) I 
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Discussion 
In this study, we report the identification of RACKI as PCBPI interacting protein and 
have presented evidence for the physical interaction between RACKI and PCBPI. The physical 
interaction between RACKI and PCBPI was studied by two independent experiments; the 
bacteria two hybrid screening and co-immunoprecipitation assay of endogenous proteins. 
PCBP 1 is known to act as a transcriptional regulator of hMOR gene (Ko and Loh, 2005, 
Malik et aI., 2006, Cook et at., 2010). Therefore, it was hypothesized that the physical interaction 
between PCBPI and RACKI can modulate the hMOR gene expression. RACKI functional 
effect of RACKI on the hMOR gene expression is supported by the findings that RACKI 
overexpression decreases the hMOR promoter activity (Fig. 13). RACK 1 siRNA knockdown 
experiments, have shown to decrease RACKI mRNA levels which causes increase in the hMOR 
mRNA and hMOR mRNA levels (Figs. 14 and 15). The changes in the hMOR and RACKI 
mRNA levels were evident faster within forty-eight hours of transfection when compared to 
changes in the RACK I protein levels (Fig. 16), which required seventy-two hours after 
transfection. 
RACKI was originally cloned from both a chicken liver cDNA library and a human B­
lymphoblastic cell line and is referred to as C12.3 or HI2.3, respectively (Guillemot et aI., 1989). 
The name RACK I was adopted by a group describing its ability to bind activated Protein kinase 
C (PKC) (Mochly-Rosen and Gordon, 1998). RACKI is a 36 kDa cytosolic protein containing 
Trp-Asp 40 (W040) repeats that are responsible for mediating its protein-protein interaction 
properties (Imai et at., 2009). Using the bacteria two hybrid system, the interaction site of 
RACK 1 and PCBPI was mapped. The deletion studies have confirmed that the binding of 
RACKI and PCBPI requires a critical region in the N-terminus wi~hin the WO 7 repeat of J 
! 
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the other partners. An interacting protein partner would interact at the sides of the propeller in 

addition to interactions with other protein partner below the propeller or along its circumference ) 
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RACKI (Figs. 9 and 12), for WD7 alone has shown to possess the ability to interact with 
PCBPI. The other six WD domains have shown to possess minor to no ability to interact with 
RACKI. These results were also supported by the serial WD deletion experiments (Fig. 12), 
where WD7 alone has shown to possess strongest ability to interact with PCBP 1. The differences 
in the interaction capacity of the WD domains of RACK 1 could be due to the differences in the 
individual WD motifs, although each of the WD domains has a similar bladed structure. 
The presence of WD motifs makes RACK 1 share structural properties with the G protein 
psubunit while the WD repeats of RACK 1 form a seven-bladed propeller structure where each 
blade is made up of p sheets (Buensuceso et aI., 2001, Sondek and Siderovski, 2001). In a 
diverse range of species from plants and arthropods like Drosophila melanogaster to nematodes 
like Caenorhabditis elegans, the WD repeat sequence is well conserved (Nakashima et aI., 2008, 
Ai et aI., 2009). Despite their highly conserved structural motif, WD40 proteins play very diverse 
functions due to the ability of these proteins to coordinate the binding of a variety of proteins 
through the individual blades (Chen et aI., 2004). 
In most of the WD proteins, the WD repeats are connected by loops of variable size 
which project above and below of the propeller structure, the psheets are more conserved both in 
the size and properties as compared to the loops. The difference in the structural properties of the 
WD repeats are responsible for providing salient features to each member of the WD family 
(Garcia-Higuera et aI., 1998). In RACKl, the distinct sheets are splayed outward, giving it a 
conical shape with the three interaction sites top, bottom and the circumference. The main chain 
hydrogen bond formed between the pstrands in the propeller itself supports the interactions with 
\
• 
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(Sklan et al., 2006). The seventh WD repeat of RACK 1 has been known to interact with several 
proteins examples of these protein partners are integrin p-sub unit, Protein phosphatase 2 (PP2A) 
and Factor associated with neural sphingomyelinase activation (FAN) (Liliental and Chang, 
1998, Tcherkasowa et aL, 2002, Kiely et aL, 2008). RACKI interacts with the androgen receptor 
and promotes cross talk via PKC signaling through the WD 6 domain and domains WD 1-4 are 
responsible for RACK I-insulin receptor! IGF I R interaction (Rigas et aI., 2003, Zhang et aI., 
2006). Thus, taken together RACKI is known to interact with several proteins via one or several 
of its characteristic WD domains. 
The RACKI gene is universally expressed in the tissues of mammals and humans 
including brain, liver, and spleen, suggesting that it has an important functional role (Guillemot 
et at, 1989, Chou et al., 1999). There are several studies reporting various functional roles of I 
RACK}, RACKI appears to serve as a "scaffold" or "anchor" protein for PKC isoforms, in this I
f 
mode of function it serves neither as a substrate nor an inhibitor, but enables translocation and 
stabilization of PKC isoforms (Mochly-Rosen and Gordon, 1998). In aging rat brains studies 
have demonstrated that reduction of RACKI levels correlates to malfunctioning of PKC 
translocation (Battaini et al., 1997). The disruption of PKC-RACK I interactions have shown to 
impair insulin-induced kinase translocation and Xenopus oocyte maturation and in 
cardiomyocytes the calcium channels are regulated by RACKI (Ron et aI., 1995, Zhang et aL, 
2006). Studies have suggested that RACKI-Src kinase interaction causes a decrease in the level 
of Src activity and cell growth rates in NIH 3T3 cells that stably over-express RACK I (Chang et f 
r 
aI., 1998). The data presented here along with previous published work suggests that RACK I 
plays opposing roles depending on the protein with which it interacts. 
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In this study, we have shown that RACKl localizes mainly in the cytosol when 
compared to the nucleus (Fig. 4), suggesting its potential functional role in the nucleus. To shed 
insight on the functional effect of the interaction between RACKl and PCBPl, spatial 
significance of this interaction was studied. Results indicate that the interaction between RACKl 
and PCBPl occurs outside the nucleus in the cytosol. Post translational modification of PCBPl 
in form phosphorylation has shown to affect nuclear translocation ability (Meng et aI., 2007) and 
may affect the interaction between RACKl and PCBPl within the nucleus. 
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Using human neuronal NMB cell system how RACKl and PCBPl interact and modulate 
r 
the hMOR gene expression is proposed in the above schematic representation. SiRNA mediated i 
RACKl knockdown decreases expression of RACKl protein (I), as a result of this RACKl t 
knockdown, PCBPI and RACK! do not form an interaction complex (2), PCBPl now trans I 
locates to the nucleus (3), where it is known to act as a transcription regulator ofhMOR gene by l 
iincreasing the MOR transcription (Ko and Loh, 2005, Malik et aI., 2006, Cook et aI., 2010) and 
increases the expression hMOR protein level via post-transcriptional events (4) as well as 
translational and post-translational events (5). Conversely, when RACKl is overexpressed via 
transfection, RACKI interacts with PCBPI generating more PCBPl·RACKI complexes thus 
limiting the availability of free PCBPI to regulate the hMOR expression by translocating in to 
the nucleus. I,, 
: 
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Conclusion 
In conclusion, this study has identified RACK! as the PCBPI interacting protein and can 
regulate the hMOR gene expression using a human neuronal cell system. This new functional 
role of RACK 1 and its interaction with PCBPI can provide further understanding about hMOR 
regulation. 
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